The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans
Open accessAbstract
Recent observations demonstrated that fluconazole plus cyclosporine (Cy) synergistically killed Candida albicans in vitro. This combination was tested in rats with C. albicans experimental endocarditis. The MICs of fluconazole and Cy for the test organism were 0.25 and >10 mg/liter, respectively. Rats were treated for 5 days with either Cy, amphotericin B, fluconazole, or fluconazole-Cy. Although used at high doses, the peak concentrations of fluconazole in the serum of rats (up to 4.5 mg/liter) were compatible with high-dose fluconazole therapy in humans. On the other hand, Cy concentrations in serum (up to 4.5 mg/liter) were greater than recommended therapeutic levels. Untreated rats demonstrated massive pseudohyphal growth in both the vegetations and the kidneys. However, only the kidneys displayed concomitant polymorphonuclear infiltration. The therapeutic results reflected this dissociation. In the vegetations, only the fungicidal fluconazole-Cy combination significantly decreased fungal densities compared to all groups, including amphotericin B ( P < 0.0001). In the kidneys, all regimens except the Cy regimen were effective, but fluconazole-Cy remained superior to amphotericin B and fluconazole alone in sterilizing the organs ( P < 0.0001). While the mechanism responsible for the fluconazole-Cy interaction is hypothetical, this observation opens new perspectives for fungicidal combinations between azoles and other drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a mouse model of invasive candidiasis by C. albicans, the efficacy of fluconazole was increased by co-administration of FK506 (56).”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [56]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Antibiotics in Laboratory Medicine.
Lorian, V. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,809
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,013
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
Fruman, D. A., Klee, C. B., Bierer, B. E., & Burakoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3686 · Cited by 823
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Self-citation
Research works printed but not linked: 2
- Osato M. S. Roussel K. R. Wilhelmus K. R. Jones D. B. In vitro and in vivo antifungal activity of cyclosporine. Transplant. Proc. 15 1983 2927 2930
- Wood A. J. Maurer G. Niederberger W. Beveridge T. Cyclosporine: pharmacokinetics, metabolism, and drug interactions. Transplant. Proc. 15 1983 2409 2412
Cited by
Sorted by citations
Items 101–113 of 113
Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
Victorio, G. B., Brennan-Bourdon, L. M., García‐Benavides, L., Huerta-Olvera, S. G., Plascencia-Hernández, A., Villanueva, J., Martínez‐López, E., & Hernández‐Cañaveral, I. (2017) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160494 · Cited by 4
The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na+/H+ Exchangers
Vu, K., Blumwald, E., & Gelli, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.673035 · Cited by 4
Immunosuppresseurs et antifongiques
Rammaert, B., & Lortholary, O. (2010) · médecine/sciences · doi:10.1051/medsci/2010268-9747 · Cited by 4
Keynan, Y., & Rubinstein, E. (2007) · Current Fungal Infection Reports · doi:10.1007/s12281-007-0005-8 · Cited by 3
Şallı, G. A., Erdem, T. L., Ünlü, Ö., Demırci, M., Eğil, E., Katiboğlu, A., & Zi̇nci̇r, Ö. Ö. (2021) · Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi · doi:10.17567/ataunidfd.947517 · Cited by 1
Hosseini, S. M. K., Alizadeh, F., Nouripour‐Sisakht, S., & Khodavandi, A. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e19897 · Cited by 1
Evolution of Drug Resistance in Fungi
Hill, J. A., Hoot, S. J., White, T. C., & Cowen, L. E. (2012) · Wiley eBooks · doi:10.1002/9781118308165.ch8 · Cited by 1
In vitro interaction between antifungals and other agents against pathogenic fungi
Afeltra, J. (2003) · Radboud Repository (Radboud University) · Cited by 1
Gerardo, B., Gabriela, C., Carlos, R., Arturo, P. H., Miguel, D., & Iván, H. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Şallı, G. A., Erdem, T. L., Ünlü, Ö., Demırcı, M., Eğil, E., Katiboğlu, A., & Zi̇nci̇r, Ö. Ö. (2020) · DergiPark (Istanbul University)
Rodrigues, M. M. (2012) · Cited by 1
Metadata
- Authors
- Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- <!--label omitted: 1-->Division of Infectious Diseases, Department of Internal Medicine,1 and
- <!--label omitted: 2-->Institute of Microbiology,2 Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-11
- Volume
- 44
- Issue
- 11
- Pages
- 2932-2938
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC101583
- OpenAlex
- W2080315399
- Cited by
- 113
- References
- 43
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 4
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- fluconazole, cyclosporine, Candida albicans, fungal endocarditis, combination antifungal therapy, amphotericin B, drug interactions, pseudohyphal growth, vegetation, serum drug concentration
- MeSH terms
- Animals, Antifungal Agents, Candida albicans, Candidiasis, Disease Models, Animal, Drug Resistance, Microbial, Drug Therapy, Combination, Endocarditis, Female, Kidney, Microbial Sensitivity Tests, Fluconazole, Cyclosporine, Treatment Outcome, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
